Search results for "acetate"

showing 10 items of 756 documents

Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients

2013

Asthma is a disease of all ages. This assumption has been challenged in the past, because of several cultural and scientific biases. A large body of evidence has accumulated in recent years to confirm that the prevalence of asthma in the most advanced ages is similar to that in younger ages. Asthma in the elderly may show similar functional and clinical characteristics to that occurring in young adults, although the frequent coexistence of comorbid conditions in older patients, together with age-associated changes in the human lung, may lead to more severe forms of the disease. Management of asthma in the elderly follows specific guidelines that apply to all ages, although most behaviors ar…

CyclopropanesMalePediatricsmedicine.medical_specialtyQuinolineDiseaseReviewSettore MED/10 - Malattie Dell'Apparato Respiratorioairway inflammationAcetatesSulfidesAnti-asthmatic AgentMaintenance therapyleukotriene antagonistmedicineAnti-Asthmatic AgentHumansAnti-Asthmatic AgentsYoung adultMontelukastAsthmaAgedAged 80 and overLeukotrienetreatmentAcetatebusiness.industryagingGeneral MedicineasthmaMiddle Agedmedicine.diseaseClinical trialleukotriene antagonistsPhysical therapyQuinolinesFemaleGeriatrics and GerontologybusinessHumanmedicine.drugClinical Interventions in Aging
researchProduct

Effects of exercise training and montelukast in children with mild asthma

2008

Data from the general population suggest that habitual exercise decreases bronchial responsiveness, but the possible role of exercise in asthmatics is undefined. The leukotriene receptor antagonist montelukast decreases bronchial responsiveness and exercise-induced symptoms in asthmatic children. This randomized study in children with mild asthma evaluated the combined effects of aerobic training for 12 wk and montelukast or placebo on bronchial responsiveness (BHR) to methacholine, exercise-induced bronchoconstriction (EIB), inflammatory markers in exhaled breath condensate (EBC), and asthma exacerbations.Fifty children (mean age +/- SD: 10.2 +/- 2.4 yr) with mild stable asthma were random…

CyclopropanesMaleQuinolineAcetatesSettore BIO/09 - Fisiologiaimmune system diseasesMedicineOrthopedics and Sports MedicineAnti-Asthmatic AgentsChildMethacholine ChlorideLeukotrieneeducation.field_of_studyrespiratory systemExercise TherapyAsthma Exercise-InducedBreath TestsItalyExhalationAnesthesiaQuinolinesFemalemedicine.drugHumanmedicine.medical_specialtyBreath TestBronchoconstrictionPopulationPhysical Therapy Sports Therapy and RehabilitationPhysical exerciseSulfidesSettore MED/10 - Malattie Dell'Apparato RespiratorioInternal medicineAerobic exerciseHumansAnti-Asthmatic AgenteducationMontelukastAsthmabusiness.industryLeukotriene receptorAcetateBronchospirometrymedicine.diseaseAsthmarespiratory tract diseasesPhysical FitnessPhysical FitneExercise TestMethacholinebusiness
researchProduct

Can the response to Omalizumab be influenced by treatment duration? A real-life study

2017

Objective It is unknown whether Omalizumab effectiveness changes over the course of time. Our retrospective real-life study tried to analyze whether Omalizumab response may be influenced by treatment duration. Methods 340 severe asthmatics treated with Omalizumab for different periods of time were recruited. They were subdivided into 4 groups according to the Omalizumab treatment length: 60 months. Omalizumab treatment results (FEV1, exacerbations, ACT, SABA use, asthma control levels, medications used e and ICS doses) were compared. Results ACT, exacerbations, GINA control levels, ICS doses and SABA use were similar in all groups with different Omalizumab treatment durations. Using a linea…

CyclopropanesMaleSevere asthmaTime FactorsTreatment durationQuinolineEffectivenessOmalizumabOmalizumabAcetatesAdrenal Cortex Hormone0302 clinical medicineAdrenal Cortex HormonesRetrospective StudieForced Expiratory VolumeMedicinePharmacology (medical)Anti-Asthmatic Agents030212 general & internal medicineLead (electronics)Adrenergic beta-AgonistConfoundingEffectiveneReal-lifeResponseAdrenergic beta-AgonistsMiddle AgedTreatment OutcomeEffectiveness; Omalizumab; Real-life; Response; Severe asthma; Treatment duration; Pulmonary and Respiratory Medicine; Biochemistry (medical); Pharmacology (medical)QuinolinesLinear ModelFemaleHumanmedicine.drugAdultPulmonary and Respiratory Medicinemedicine.medical_specialtyTime FactorSulfidesSettore MED/10 - Malattie Dell'Apparato RespiratorioTreatment duration03 medical and health sciencesInternal medicineHumansAnti-Asthmatic AgentMontelukastRetrospective StudiesAsthmaAcetatebusiness.industryBiochemistry (medical)Retrospective cohort studymedicine.diseaseAsthmaDiscontinuationSurgery030228 respiratory systemLinear ModelsbusinessPulmonary Pharmacology & Therapeutics
researchProduct

Enantio- and diastereocontrol in intermolecular cyclopropanation reaction of styrene catalyzed by dirhodium(II) complexes with bulky ortho-metalated …

2004

Enantiomerically pure dirhodium(II) complexes with ortho-metalated p-substituted aryl phosphines have been shown to be enantio- and diastereoselective in the cyclopropanation of styrene by ethyl diazoacetate. Enantioselectivities up to 91% and diastereoselectivities up to 90% are observed for ethyl cis-2-phenylcyclopropanecarboxylate. Estevan Estevan, Francisco, Francisco.Estevan@uv.es ; Lahuerta Peña, Pascual, Pascual.lahuerta@uv.es ; Lloret Fillol, Julio, Julio.Lloret@uv.es ; Sanau Torrecilla, Mercedes, Mercedes.Sanau@uv.es ; Ubeda Picot, M Angeles, Angeles.Ubeda@uv.es ; Vila Gomez, Jaume Llorenc, Jaume.Vila@uv.es

CyclopropanesModels MolecularReactionPhosphinesCyclopropanationUNESCO::QUÍMICAIntermolecularCrystallography X-RayMedicinal chemistryHydrocarbons Aromatic:QUÍMICA [UNESCO]CatalysisStyrenesCatalysisStyrenechemistry.chemical_compoundEthyl diazoacetateOrganometallic CompoundsMaterials ChemistryOrganic chemistryRhodiumIntermolecular ; Reaction ; Dirhodium ; Phosphines ; CyclopropanationMolecular StructureCyclopropanationArylIntermolecular forceUNESCO::QUÍMICA::Química analíticaMetals and AlloysStereoisomerismGeneral MedicineGeneral ChemistryDirhodiumSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialschemistryCyclization:QUÍMICA::Química analítica [UNESCO]Ceramics and Composites
researchProduct

Anti-inflammatory medications for the treatment of pediatric obstructive sleep apnea

2020

CyclopropanesPulmonary and Respiratory Medicinemedicine.medical_specialtyAdolescentmedicine.drug_classAnti-Inflammatory AgentsAdministration OralAcetatesSulfidesAnti-inflammatorylaw.inventionRandomized controlled trialAdrenal Cortex HormoneslawInternal medicinemedicineHumansChildAdministration IntranasalMontelukastSleep Apnea Obstructivebusiness.industryInfantmedicine.diseaseObstructive sleep apneaTreatment OutcomeChild PreschoolPediatrics Perinatology and Child HealthQuinolinesLeukotriene Antagonistsbusinessmedicine.drugPaediatric Respiratory Reviews
researchProduct

Efficacy, tolerability, and safety of montelukast versus finasteride for the treatment of moderate acne in women: A prospective, randomized, single-b…

2021

Background Acne is a chronic inflammatory skin disease which involves the pilosebaceous unit. Tissue inflammation isone of the crucial mechanisms, amongst others. Of the various cytokines, leukotriene B4 (LT-B4) is the most potentleucocyte chemotactic mediator. Montelukast is an antagonist of the LT-B4 receptor. Finasteride is an antiandrogen whichspecifically inhibits the 5α-reductase enzyme. Aims This study aimed at comparing the efficacy, tolerability and safety of montelukast versus finasteride in the treatmentof moderate acne in women. Patients/method This randomized, single-blinded, prospective trial over 12 weeks recruited 65 female subjects with moderate acne vulgaris (Global Acne G…

Cyclopropanesmedicine.medical_specialtymedicine.drug_classDermatologyAcetatesSulfidesAntiandrogenGastroenterologylaw.inventionchemistry.chemical_compoundRandomized controlled triallawInternal medicineAcne VulgarismedicineHumansProspective StudiesAdverse effectAcneMontelukastbusiness.industryFinasterideAntagonistmedicine.diseasechemistryTolerabilityFinasterideQuinolinesFemalebusinessmedicine.drugJournal of cosmetic dermatologyREFERENCES
researchProduct

Purification of Leuconostoc mesenteroides citrate lyase and cloning and characterization of the citCDEFG gene cluster

1998

ABSTRACT A citrate lyase (EC 4.1.3.6 ) was purified 25-fold from Leuconostoc mesenteroides and was shown to contain three subunits. The first 42 amino acids of the β subunit were identified, as well as an internal peptide sequence spanning some 20 amino acids into the α subunit. Using degenerated primers from these sequences, we amplified a 1.2-kb DNA fragment by PCR from Leuconostoc mesenteroides subsp. cremoris . This fragment was used as a probe for screening a Leuconostoc genomic bank to identify the structural genes. The 2.7-kb gene cluster encoding citrate lyase of L. mesenteroides is organized in three open reading frames, citD , citE , and citF , encoding, respectively, the three ci…

DNA BacterialATP citrate lyaseMolecular Sequence DataGene ExpressionBiologymedicine.disease_causeMicrobiologyBacterial ProteinsCarbon-Sulfur LigasesMultienzyme ComplexesGene clusterAcyl Carrier ProteinEscherichia colimedicineLeuconostocAmino Acid SequenceCloning MolecularMolecular BiologyEscherichia coliBase SequenceSequence Homology Amino AcidStructural geneOxo-Acid-LyasesSequence Analysis DNALyasebiology.organism_classificationEnzymes and ProteinsMolecular biologyOxaloacetate decarboxylaseBiochemistryGenes BacterialLeuconostoc mesenteroidesMultigene FamilyCoenzyme A-TransferasesLeuconostoc
researchProduct

Tumor necrosis factor-alpha converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulat…

2003

Tumor necrosis factor-alpha converting enzyme (TACE or ADAM17) is a member of the ADAM (a disintegrin and metalloproteinase) family of type I membrane proteins and mediates the ectodomain shedding of various membrane-anchored signaling and adhesion proteins. TACE is synthesized as an inactive zymogen, which is subsequently proteolytically processed to the catalytically active form. We have identified the proprotein-convertases PC7 and furin to be involved in maturation of TACE. This maturation is negatively influenced by the phorbol ester phorbol-12-myristate-13-acetate (PMA), which decreases the cellular amount of the mature form of TACE in PMA-treated HEK293 and SH-SY5Y cells. Furthermore…

DNA ComplementaryTime FactorsADAM10Blotting WesternGenetic VectorsADAM17 ProteinTransfectionBiochemistryCell LineAmyloid beta-Protein PrecursorAlzheimer DiseaseZymogenEndopeptidasesPhorbol EstersCell AdhesionTumor Cells CulturedAnimalsAspartic Acid EndopeptidasesHumansSubtilisinsProtein kinase A signalingFurinProtein Kinase CProtein kinase CFurinMetalloproteinasebiologyChemistryMetalloendopeptidasesCyclic AMP-Dependent Protein KinasesPeptide FragmentsRatsCell biologyADAM ProteinsEctodomainBiochemistrybiology.proteinTetradecanoylphorbol AcetateCattleTumor necrosis factor alphaProprotein ConvertasesAmyloid Precursor Protein SecretasesSignal TransductionEuropean Journal of Biochemistry
researchProduct

Isolation and identification of new anthraquinones from Rhamnus alaternus L and evaluation of their free radical scavenging activity

2018

From the butanolic and the ethyl acetate extracts of Rhamnus alaternus L root bark and leaves, three new anthraquinone glycosides, alaternosides A-C (1,4,6,8 tetrahydroxy-3 methyl anthraquinone 1-O-ß-D-glucopyranosyl-4,6-di-O-α-L-rhamnopyranoside (1); 1,2,6,8 tetrahydroxy-3 methyl anthraquinone 8-O-ß-D-glucopyranoside (2) and 1, 6 dihydroxy-3 methyl 6 [2′-Me (heptoxy)] anthraquinone (3)) were isolated and elucidated together with the two known anthraquinone glycosides, Physcion-8-O-rutinoside (4) and emodin-6-O-α-L-rhamnoside (5) as well as with the known kaempferol-7-methylether (6), β-sitosterol (7) and β-sitosterol-3-O-glycoside (8). Their chemical structures were elucidated using spectr…

DPPHRadicalEthyl acetateAnthraquinonesPlant Science01 natural sciencesBiochemistryAnthraquinoneMedicinal chemistryAnalytical Chemistrychemistry.chemical_compoundRhamnus alaternusAnthraquinonesGlycosidesKaempferolschemistry.chemical_classificationbiologyMolecular Structure010405 organic chemistryPlant ExtractsOrganic ChemistryGlycosideFree Radical Scavengersbiology.organism_classification0104 chemical sciences010404 medicinal & biomolecular chemistryRhamnuschemistryvisual_artvisual_art.visual_art_mediumBark
researchProduct

Insertion of isocyanides into the 2-one-1-propyl—palladium(II) bond: A convenient synthetic route to C1-palladated 1-amino-3-one-1-butene compounds

1984

Abstract Migratory insertion of isocyanides CNR (R = p -C 6 H 4 OMe, Me) into the palladium—carbon σ bond of trans -[PdCl(CH 2 COMe)(PPh 3 ) 2 ] (I) yields the 1-amino-3-one-1-butenyl complexes trans -[PdCl{C(NHR)CHCOMe}(PPh 3 ) 2 ] (IIa, R = p -C 6 H 4 OMe; IIb, R = Me), which have been characterized by IR, 1 H and 31 P NMR spectra. The reaction of IIa with nickel acetate gives a diamagnetic bischelate complex of the type [Ni(ON) 2 ] , in which the deprotonated 1-amino-3-one-1-butenyl moiety acts as a bidentate O,N ligand.

DenticityChemistryLigandStereochemistryOrganic ChemistryMigratory insertionchemistry.chemical_elementNickel(II) acetateNuclear magnetic resonance spectroscopyBiochemistryInorganic Chemistrychemistry.chemical_compoundMaterials ChemistryMoietyPhysical and Theoretical ChemistryTriphenylphosphinePalladiumJournal of Organometallic Chemistry
researchProduct